Central pontine myelinolysis diagnostic study of choice
Central pontine myelinolysis Microchapters |
Differentiating Central pontine myelinolysis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Central pontine myelinolysis diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Central pontine myelinolysis diagnostic study of choice |
FDA on Central pontine myelinolysis diagnostic study of choice |
CDC on Central pontine myelinolysis diagnostic study of choice |
Central pontine myelinolysis diagnostic study of choice in the news |
Blogs on Central pontine myelinolysis diagnostic study of choice |
Risk calculators and risk factors for Central pontine myelinolysis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Brain MRI is the gold standard test for the diagnosis of central pontine myelinolysis. The following findings on performing Brain MRI are confirmatory for central pontine myelinolysis: T2 hyperintensity in the central pontine region in the axial plane and hyperintense lesion in the midpons in the midsagittal T2-weighted MRI.
Diagnostic Study of Choice
Study of choice
Brain MRI is the gold standard test for the diagnosis of central pontine myelinolysis.
Diagnostic results
The following findings on performing Brain MRI are confirmatory for central pontine myelinolysis:
- T2 hyperintensity in the central pontine region in the axial plane
- Hyperintense lesion in the midpons in the midsagittal T2-weighted MRI